Medical Devices US

US Neurorehabilitation Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

US Neurorehabilitation Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $702.7 Mn Placeholder estimate
Estimate 2025 $765.3 Mn 38.8% of the global market
Projected 2034 $1.65 Bn 115.4% Adds $883.1 Mn over 9 forecast years
CAGR 2025–2034 8.9% Faster than 67% of 180 Medical Devices markets here
Key players 5 Companies profiled
  • US is 38.82% of the global market.
  • In North America, the largest is US (this report) at $765.3 Mn.
  • Fastest growing: Canada at 10.8% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$883.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Neurorehabilitation Devices Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $702.7 Mn — —
2025 (base) $765.3 Mn +$62.5 Mn —
2026 (forecast) $833.4 Mn +$68.1 Mn +8.9%
2027 (forecast) $907.6 Mn +$74.2 Mn +18.6%
2028 (forecast) $988.3 Mn +$80.8 Mn +29.1%
2029 (forecast) $1.08 Bn +$88.0 Mn +40.6%
2030 (forecast) $1.17 Bn +$95.8 Mn +53.2%
2031 (forecast) $1.28 Bn +$104.3 Mn +66.8%
2032 (forecast) $1.39 Bn +$113.6 Mn +81.6%
2033 (forecast) $1.51 Bn +$123.7 Mn +97.8%
2034 (forecast) $1.65 Bn +$134.7 Mn +115.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

US Neurorehabilitation Devices Market Analysis at a glance
Market size, 2025$765.3 Mn placeholder estimate
Forecast, 2034$1.65 Bn placeholder estimate
Growth (CAGR), 2025–20348.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, condition and end user (see all)
Key playersHocoma (DIH), Ekso Bionics, ReWalk Robotics, Bioness, MindMaze (see all)
Regulator in the USFDASource: US Food and Drug Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The US Neurorehabilitation Devices Market Analysis Executive Summary

Neurorehabilitation devices help people recover movement after stroke or brain injury, using robots, stimulation and virtual reality.

Key segments of the neurorehabilitation Devices market include product (Rehabilitation Robots, Brain Stimulation Devices and Wearable Sensors) and condition (Stroke, Spinal Cord Injury and Traumatic Brain Injury).

Bar chart: US Neurorehabilitation Devices market size, 2024–2034, placeholder estimates. $702.7 Mn in 2024, $765.3 Mn in 2025 and $1.65 Bn in 2034, 8.9% CAGR.
US Neurorehabilitation Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

US Neurorehabilitation Devices Market Dynamics

Market Growth Drivers

An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the neurorehabilitation Devices market.

Opportunity

Biomarker-guided treatment, earlier diagnosis and new device-based therapies give the neurorehabilitation Devices market strong room to grow.

Market Restraints

Hard-to-reach brain targets, high failure rates in trials, side effects and high prices for new therapies hold back the neurorehabilitation Devices market.

Competitive Landscape for Neurorehabilitation Devices Market in the US

The neurorehabilitation Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Neurorehabilitation Devices Market in the US

Neurorehabilitation Devices in the US: rules and payment

The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA).⁠[1] Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS).⁠[2]

[1] US Food and Drug Administration. Checked 14 Nov 2026.

[2] Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how neurorehabilitation Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in the US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Neurorehabilitation Devices right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Neurorehabilitation Devices in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 19 Nov 2026.

Free data on this topic

Inside the US

Quick answers

Frequently asked questions

How big is the Neurorehabilitation Devices market in the US?
Placeholder estimate: about $765.3 Mn in 2025, rising to about $1.65 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Neurorehabilitation Devices market in the US growing?
Placeholder estimate: about 8.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Neurorehabilitation Devices market report cover?
The report splits the market by product (Rehabilitation Robots, Brain Stimulation Devices, Wearable Sensors, VR Systems), condition (Stroke, Spinal Cord Injury, Traumatic Brain Injury) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Neurorehabilitation Devices market?
Key players include Hocoma (DIH), Ekso Bionics, ReWalk Robotics, Bioness and MindMaze.
What is driving the Neurorehabilitation Devices market?
An ageing population, more people living with brain and nerve diseases, better diagnosis and the first disease-modifying treatments are driving the neurorehabilitation Devices market.
Who regulates Neurorehabilitation Devices in the US?
The FDA clears or approves medical devices by risk class, through 510(k) clearance, De Novo classification or premarket approval (PMA). Source: US Food and Drug Administration. Checked 14 Nov 2026.
How is healthcare paid for in the US?
Medicare covers people aged 65 and over and some younger people with disabilities, and Medicaid covers many people on low incomes; both are run with the Centers for Medicare & Medicaid Services (CMS). Source: Centers for Medicare & Medicaid Services. Checked 14 Nov 2026.
How much research is published on Neurorehabilitation Devices?
PubMed lists 427 papers on Neurorehabilitation Devices added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in US

See all

Related on rehabilitation and stroke

See the topic